P S A Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 06-07-2024
- Paid Up Capital ₹ 0.49 M
as on 06-07-2024
- Company Age 37 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -99.56%
(FY 2019)
- Profit -25.67%
(FY 2019)
- Ebitda -14.87%
(FY 2019)
- Net Worth -3.94%
(FY 2019)
- Total Assets -3.72%
(FY 2019)
About P S A Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.49 M, as per Ministry of Corporate Affairs (MCA) records.
Piyush Sharma and Dipank Sharma serve as directors at the Company.
- CIN/LLPIN
U74899DL1987PTC026593
- Company No.
026593
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jan 1987
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at P S A Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Piyush Sharma  | Director | 19-Oct-1996 | Current |
| Dipank Sharma | Director | 19-Oct-1996 | Current |
Financial Performance of P S A Pharma.
P S A Pharma Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 99.56% decrease. The company also saw a substantial fall in profitability, with a 25.67% decrease in profit. The company's net worth dipped by a decrease of 3.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of P S A Pharma?
In 2019, P S A Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Divya And Co Private LimitedActive 40 years 11 monthsPiyush Sharma and Dipank Sharma are mutual person
Metropark Developers And Housing Infrastructure Private LimitedActive 18 years 4 monthsPiyush Sharma and Dipank Sharma are mutual person
Metropark Infratech And Realty Developments Private LimitedActive 14 years 2 monthsPiyush Sharma and Dipank Sharma are mutual person
- Quick Buildwell Private LimitedActive 18 years 3 months
Piyush Sharma and Dipank Sharma are mutual person
- Metropark Datatech Private LimitedActive 11 years 10 months
Piyush Sharma and Dipank Sharma are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at P S A Pharma?
Unlock and access historical data on people associated with P S A Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of P S A Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped P S A Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
